Immunome (IMNM) has released an update.
The Company has recently updated its business descriptions and risk factors, which can be found in the latest filings with the SEC. Investors seeking insights into the Company’s operations and potential challenges will find this information in the newly attached exhibits.
For further insights into IMNM stock, check out TipRanks’ Stock Analysis page.
